AsiDNA
Nucleic acidexperimental
Clinical trial activity
4 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Apr 5, 2018 (NCT03579628)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- CandidaAGONIST
Candida agonist
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05700669 | Phase 1/Phase 2 (Phase 2) | Feb 20, 2023 | Valerio Therapeutics |
| NCT05394558 | Phase 1/Phase 2 (Phase 2) | May 27, 2022 | Curie Institute |
| NCT04826198 | Phase 1/Phase 2 (Phase 2) | Oct 5, 2020 | Institut Gustave Roussy |
| NCT03579628 | Phase 1 | Apr 5, 2018 | Valerio |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Curie Institute | Academic/Hospital | 1 | 1 | 1 | 2022 |
| Institut Gustave Roussy | Academic/Hospital | 1 | 1 | 1 | 2020 |
| Valerio | For profit | 1 | 1 | 1 | 2018 |
| Valerio Therapeutics | For profit | 1 | 1 | 1 | 2023 |
4 organizations
Page 1 / 1